Article

Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information –an essential step to facilitate decision making

2020-04-03

Abstract excerpt

<h4>Background</h4> Many trials are now underway to inform decision-makers on potential effects of treatments for COVID-19. To provide sufficient information for all involved decision-makers (clinicians, public health authorities, drug regulatory agencies) a multiplicity of endpoints must be considered. It is a challenge to generate detailed high quality evidence from data while ensuring fast availability and eval...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5df08aec-a293-535c-a564-9fca7d86ee48
DOI: 10.1101/2020.03.31.20049007

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information –an essential step to facilitate decision makingDOI 10.1101/2020.03.31.20049007Read

Outcomes evaluated in controlled clinical trials on the management of COVID-19: A methodological systematic reviewSemantic proximity Read

How the clinical research community responded to the COVID-19 pandemic: An analysis of the COVID-19 clinical studies in ClinicalTrials.govSemantic proximity Read

Impact of remdesivir for the treatment of COVID-19 during the first wave in SpainSemantic proximity Read

Baseline results of a living systematic review for COVID-19 clinical trial registrationsSemantic proximity Read

The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions.Semantic proximity Read

A snapshot of the ongoing clinical research on COVID-19Semantic proximity Read

Efficacy and safety outcomes in randomized controlled trials investigating hydroxychloroquine for COVID-19Semantic proximity Read

High-Throughput Observational Evidence Generation Using Linked Electronic Health Record and Claims DataSemantic proximity Read

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trialsSemantic proximity Read

Characteristics of COVID-19-related Clinical Studies and Factors Affecting the Recruitment and Completeness: a Large Cross-sectional StudySemantic proximity Read

Characteristics of Registered Systematic Reviews on Treatment for COVID-19 in Prospero PlatformSemantic proximity Read

HBOT, hyperinflammatory burden, comorbidity burden and drug exposure in relation to repeated-measures respiratory severity in hospitalized adults with COVID-19: a post hoc secondary analysis of a randomized clinical trialSemantic proximity Read